UDENAFIL - A NEW PHOSPHODIESTERASE-5 (PDE-5) INHIBITOR - IN PORTAL HYPERTENSION: AN OPEN-LABEL DOSE-FINDING TRIAL

(1) University Hospital Freiburg

(2) Lithuanian University of Health Sciences

(3) University of Bonn

(4) Gastroenterology and Endocrinology Center

(5) Martin-Luther-University Halle-Wittenberg

(6) DR. FALK PHARMA GMBH



This item was part of the Liver cirrhosis and its complications session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A88